The Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of Single Oral Doses of CH4987655 in Healthy Volunteers: Target Suppression Using a Biomarker by LEE, Lucy, HUIFENG NIU, GOELZER, Petra, DE SCHEPPER, Stefanie, YOSHIMURA, Yashushi, BARRETT, Joanne, ISHIKAWA, Yuji, WEISSGERBER, Georges, PECK, Richard, RUEGER, Ruediger, IGAWA, Yuriko, DEUTSCH, Jonathan, ISHII, Nobuya, SONG MU, SAKAMOTO, Yuuichiro, BUSSE-REID, Rachel, GIMMI, Claude

Get full text

Biomarker analysis of the phase II JO25567 study comparing erlotinib with or without bevacizumab in first-line advanced EGFR+ non-small-cell lung cancer by Nishio, Makoto, Atagi, Shinji, Goto, Koichi, Hosomi, Yukio, Seto, Takashi, Hida, Toyoaki, Nakagawa, Kazuhiko, Yoshioka, Hiroshige, Nogami, Naoyuki, Maemondo, Makoto, Nagase, Seisuke, Okamoto, Isamu, Yamamoto, Noboru, Igawa, Yuriko, Tajima, Kosei, Fukuoka, Masahiro, Yamamoto, Nobuyuki, Nishio, Kazuto

Get full text

Ethnic sensitivity assessment of the antibody–drug conjugate trastuzumab emtansine (T-DM1) in patients with HER2-positive locally advanced or metastatic breast cancer by Li, Chunze, Wang, Bei, Lu, Dan, Jin, Jin Y., Gao, Yuying, Matsunaga, Kiyoshi, Igawa, Yuriko, Nijem, Ihsan, Lu, Michael, Strasak, Alexander, Chernyukhin, Nataliya, Girish, Sandhya

Get full text

Activity of Nivolumab and Utility of Neutrophil-to-Lymphocyte Ratio as a Predictive Biomarker for Advanced Non–Small-Cell Lung Cancer: A Prospective Observational Study by Fukui, Tomoya, Okuma, Yuriko, Nakahara, Yoshiro, Otani, Sakiko, Igawa, Satoshi, Katagiri, Masato, Mitsufuji, Hisashi, Kubota, Masaru, Hiyoshi, Yasuhiro, Ishihara, Mikiko, Kasajima, Masashi, Sasaki, Jiichiro, Naoki, Katsuhiko

Get full text

Impact of neutrophil-to-lymphocyte ratio in patients with EGFR-mutant NSCLC treated with tyrosine kinase inhibitors by Ono, Taihei, Igawa, Satoshi, Kurahayashi, Shintaro, Okuma, Yuriko, Sugimoto, Ai, Kusuhara, Seiichiro, Ozawa, Takahiro, Fukui, Tomoya, Sasaki, Jiichiro, Mitsufuji, Hisashi, Yokoba, Masanori, Kubota, Masaru, Katagiri, Masato, Naoki, Katsuhiko

Get full text

Comparison of carboplatin plus etoposide with amrubicin monotherapy for extensive‐disease small cell lung cancer in the elderly and patients with poor performance status by Igawa, Satoshi, Shirasawa, Masayuki, Ozawa, Takahiro, Nishinarita, Noriko, Okuma, Yuriko, Ono, Taihei, Sugimoto, Ai, Kurahayashi, Shintaro, Sugita, Keisuke, Sone, Hideyuki, Fukui, Tomoya, Mitsufuji, Hisashi, Kubota, Masaru, Katagiri, Masato, Sasaki, Jiichiro, Naoki, Katsuhiko

Get full text